Blog / Archives
High Volatility Among Individual stocks with Few Trends…Update-4
Update-4. 4/3 11:45A... Mid and Small Cap biotechs are momentum leaders: XBI hits 2019 high at $92.50. Update-3 4/2/19... Biotechs Outperform Major Market Indices Gene therapy stocks rally big:...
Biotech Green Screen: Sketchy Recovery is Underway…Update-3
Update-3...3/29 1:15p EDT. Biotech stocks catching bids today after a choppy week of trading. We will recap our top small cap picks from the JPM Conference after the close: AMRN, GNMK and TDOC....
Biopharma Stocks Rally and Gene Therapy Stocks Are Still Hot (Not?)…Update-2
Update -2 March 24...Concerns about global growth, an inverted TSY yield curve and the German 10 year bond yield dropping below 10% triggered a major sell-off on Friday.The Russell 2000 dropped...
Biotech Stocks catch a Second Wind Helped by Tech Stocks…Update-4
ALERT 3/21/19...BIOGEN (BIIB) down 28% to $233 after dropping Alzheimer's Disease late stage trial; another failed clinical stage drug in AD. (more later). IBB down 2.5%. ====== 3/20/19...a whipsaw...
Sideways Market Vexes Traders: Biotech Stocks are Fading…Updates-3 Rally Time!
Update-3...3/11...Gene Therapy stocks go green screen! Big 5% winners: VYGR NTLA BLUE EDIT See complete list below (paste list into yahoo finance for tracking) Update-2...3/11...Market gets support...
Biotech Sell-Off: Momentum Eases on Profit Taking and Geopolitical Uncertainty…Update-2 Gene Therapy
Update-2...Biotech rally Friday and Gene Therapy stocks One clue to the stealth rally on Friday is this article in Barron's published Saturday (? hmmm) Why Big Pharma is Diving into Gene Therapy If...
Small Cap Biotechs Lead the Market in 2019 Up 20% YTD…GNMK, ONCE, XBI-Updates
Update: 1:40 EST 2/25... Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%. Another big deal as GE sells healthcare business to Danher (DHR) for $21.4B; GE up 8.26%,...
J.P.Morgan Healthcare Conference: Picks and Trades… Updates GNMK
Update: GenMark (GNMK) Soars on Q4 and Full Year 2018 Results Revenues of $70.8M were 35% over 2017 Results Q4 Revenues were $19.4M an increase of 21% over prior year. ePlex Revenues for Q4 were...
Biotech Stocks Hold After After Brief Sell-Off Last Week…Updates
Biotech Stocks Hold Despite Last Thursday's Sell-Off All in the Technicals For Now, Large Caps Look Steady Biotech ETFs lost momentum last week but held near term support near the 20 Day moving...
Life Science ETFs Performance 2018-2019: FBT is the Leader…Updates 2/7
Update 2/7/19 Mid-Day Trading : Risk Off Day The market is trending down with all major indices in the red and the XBI $81.96 down 2.75%. We sold our position in the XBI yesterday at $83+. Array...